Next Article in Journal
The Anti-AGEing and RAGEing Potential of Isothiocyanates
Previous Article in Journal
Hybrid Systems of Oleogels and Probiotic-Loaded Alginate Carriers for Potential Application in Cosmetics
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years

by
Anna Małgorzata Lankoff
1,2,*,
Malwina Czerwińska
3 and
Marcin Kruszewski
1,4
1
Centre for Radiobiology and Biological Dosimetry, Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland
2
Department of Medical Biology, Institute of Biology, Jan Kochanowski University, Uniwersytecka 15, 25-406 Kielce, Poland
3
Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (WULS-SGGW), 159c Nowoursynowska Str, 02-776 Warsaw, Poland
4
Department of Molecular Biology and Translational Research, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland
*
Author to whom correspondence should be addressed.
Molecules 2024, 29(24), 5985; https://doi.org/10.3390/molecules29245985
Submission received: 10 November 2024 / Revised: 16 December 2024 / Accepted: 16 December 2024 / Published: 19 December 2024

Abstract

The rapid development of nanotechnology during the last two decades has created new opportunities to design and generate more advanced nanotheranostics with diversified capabilities for diagnosis, drug delivery, and treatment response monitoring in a single platform. To date, several approaches have been employed in order to develop nanotheranostics. The purpose of this review is to briefly discuss the key components of nanotheranostic systems, to present the conventional and upcoming imaging and therapeutic modalities that employ nanotheranostic systems, and to evaluate recent progress in the field of cancer nanotheranostic systems in the past five years (2020–2024). Special attention is focused on the design of cancer nanotheranostic systems, their composition, specificity, potential for multimodal imaging and therapy, and in vitro and in vivo characterization.
Keywords: nanotheranostics; nanoparticles; cancer diagnosis; cancer therapy nanotheranostics; nanoparticles; cancer diagnosis; cancer therapy
Graphical Abstract

Share and Cite

MDPI and ACS Style

Lankoff, A.M.; Czerwińska, M.; Kruszewski, M. Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years. Molecules 2024, 29, 5985. https://doi.org/10.3390/molecules29245985

AMA Style

Lankoff AM, Czerwińska M, Kruszewski M. Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years. Molecules. 2024; 29(24):5985. https://doi.org/10.3390/molecules29245985

Chicago/Turabian Style

Lankoff, Anna Małgorzata, Malwina Czerwińska, and Marcin Kruszewski. 2024. "Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years" Molecules 29, no. 24: 5985. https://doi.org/10.3390/molecules29245985

APA Style

Lankoff, A. M., Czerwińska, M., & Kruszewski, M. (2024). Advances in Nanotheranostic Systems for Concurrent Cancer Imaging and Therapy: An Overview of the Last 5 Years. Molecules, 29(24), 5985. https://doi.org/10.3390/molecules29245985

Article Metrics

Back to TopTop